Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.

about

Tau: A Common Denominator and Therapeutic Target for Neurodegenerative Disorders.Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment

P2860

Q55027741-27B46BB5-5431-4F05-A89C-1E7C8C0A5597 Q57486415-6B72FD9D-6095-4677-A17A-052133B91203

P2860

Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.

Item

http://www.wikidata.org/entity/Q47842309

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Predicting progression from no ...... nt for individuals at 5 years.

@en

Predicting progression from no ...... nt for individuals at 5 years.

@nl

type

Item

label

Predicting progression from no ...... nt for individuals at 5 years.

@en

Predicting progression from no ...... nt for individuals at 5 years.

@nl

prefLabel

Predicting progression from no ...... nt for individuals at 5 years.

@en

Predicting progression from no ...... nt for individuals at 5 years.

@nl

P1476

Predicting progression from no ...... nt for individuals at 5 years.

@en

P2093

Abhay Moghekar

http://www.w3.org/2001/XMLSchema#string

Anja Soldan

http://www.w3.org/2001/XMLSchema#string

Mei-Cheng Wang

http://www.w3.org/2001/XMLSchema#string

Michael I Miller

http://www.w3.org/2001/XMLSchema#string

Ola Selnes

http://www.w3.org/2001/XMLSchema#string

Shanshan Li

http://www.w3.org/2001/XMLSchema#string

Yuxin Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Imaging markers for Alzheimer disease: which vs how

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Usefulness of data from magnetic resonance imaging to improve prediction of dementia: population based cohort study

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

Randomized controlled trials in mild cognitive impairment: Sources of variability.

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

The A4 study: stopping AD before symptoms begin?

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

P31

scholarly article

P356

10.1093/BRAIN/AWX365

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Susumu Mori

Marilyn Albert

Corinne Pettigrew

P577

2018-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29365053

http://www.w3.org/2001/XMLSchema#string

P932

5837651

http://www.w3.org/2001/XMLSchema#string

Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.

about

P2860

P2860

Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932